These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 11754411)
21. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients. Nucci M; Biasoli I; Akiti T; Silveira F; Solza C; Barreiros G; Spector N; Derossi A; Pulcheri W Clin Infect Dis; 2000 Feb; 30(2):300-5. PubMed ID: 10671332 [TBL] [Abstract][Full Text] [Related]
22. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors. Subirà M; Martino R; Franquet T; Puzo C; Altés A; Sureda A; Brunet S; Sierra J Haematologica; 2002 May; 87(5):528-34. PubMed ID: 12010668 [TBL] [Abstract][Full Text] [Related]
23. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect. Soubani AO; Qureshi MA Haematologia (Budap); 2002; 32(4):427-37. PubMed ID: 12803117 [TBL] [Abstract][Full Text] [Related]
24. Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients. Böhme A; Hoelzer D Mycoses; 1996; 39(11-12):419-26. PubMed ID: 9144997 [TBL] [Abstract][Full Text] [Related]
25. Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome. Richard C; Romón I; Baro J; Insunza A; Loyola I; Zurbano F; Tapia M; Iriondo A; Conde E; Zubizarreta A Bone Marrow Transplant; 1993 Sep; 12(3):237-41. PubMed ID: 8241983 [TBL] [Abstract][Full Text] [Related]
26. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto). Pagano L; Ricci P; Tonso A; Nosari A; Cudillo L; Montillo M; Cenacchi A; Pacilli L; Fabbiano F; Del Favero A Br J Haematol; 1997 Nov; 99(2):331-6. PubMed ID: 9375750 [TBL] [Abstract][Full Text] [Related]
27. [Invasive Aspergillosis in Hematological Patients]. Kimura S Med Mycol J; 2016; 57(2):J77-88. PubMed ID: 27251320 [TBL] [Abstract][Full Text] [Related]
28. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. Lortholary O; Meyohas MC; Dupont B; Cadranel J; Salmon-Ceron D; Peyramond D; Simonin D Am J Med; 1993 Aug; 95(2):177-87. PubMed ID: 8395142 [TBL] [Abstract][Full Text] [Related]
29. Invasive Aspergillosis among Haematological Malignancy Patients in Ghana: A Pilot Study on Prevalence and Antifungal Prophylaxis at the National Referral Hospital. Ocansey BK; Otoo B; Gbadamosi H; Opintan JA; Dei-Adomakoh Y; Kosmidis C; Denning DW West Afr J Med; 2023 Jun; 40(6):613-618. PubMed ID: 37390225 [TBL] [Abstract][Full Text] [Related]
30. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720 [TBL] [Abstract][Full Text] [Related]
31. Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. Jeffery GM; Beard ME; Ikram RB; Chua J; Allen JR; Heaton DC; Hart DN; Schousboe MI Am J Med; 1991 Jun; 90(6):685-92. PubMed ID: 2042684 [TBL] [Abstract][Full Text] [Related]
33. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation. Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292 [TBL] [Abstract][Full Text] [Related]
34. Invasive aspergillosis in a paediatric haematology department: a 15-year review. Crassard N; Hadden H; Piens MA; Pondarré C; Hadden R; Galambrun C; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y Mycoses; 2008 Mar; 51(2):109-16. PubMed ID: 18254746 [TBL] [Abstract][Full Text] [Related]
35. High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia. Lafaurie M; Lapalu J; Raffoux E; Breton B; Lacroix C; Socié G; Porcher R; Ribaud P; Touratier S; Molina JM Clin Microbiol Infect; 2010 Aug; 16(8):1191-6. PubMed ID: 19735276 [TBL] [Abstract][Full Text] [Related]
36. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602 [TBL] [Abstract][Full Text] [Related]
37. [Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia]. Andrade M A; Puga L B; Guerra C C; Molina E J; Capurro C M Rev Med Chil; 2011 Sep; 139(9):1128-34. PubMed ID: 22215390 [TBL] [Abstract][Full Text] [Related]
38. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study. Kelsey SM; Goldman JM; McCann S; Newland AC; Scarffe JH; Oppenheim BA; Mufti GJ Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802 [TBL] [Abstract][Full Text] [Related]